[Coronary reoperations: recurrence of angina and clinical outcome]

Sarūnas Kinduris1, Rimantas Benetis, Algimantas Budrikis

  • 1Institute for Biomedical Research, Kaunas University of Medicine, Lithuania. kinsar@one.lt

Insights

Coronary artery bypass reoperations show higher mortality than primary procedures but are not significantly different. Elderly patients are increasingly undergoing reoperations, often due to arterial graft atherosclerosis.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Reoperative Coronary Artery Bypass Grafting

Background:

  • Coronary artery bypass grafting (CABG) reoperations represent a small but significant portion of cardiac surgical procedures.
  • Understanding the specific challenges and outcomes of reoperative CABG is crucial for improving patient care.
  • Factors influencing morbidity and mortality in reoperative CABG require careful evaluation.

Purpose of the Study:

  • To analyze the characteristics of coronary artery bypass reoperations.
  • To identify and mitigate factors contributing to postoperative complications and mortality in reoperative CABG patients.
  • To compare outcomes of reoperative CABG with primary CABG procedures.

Main Methods:

  • Retrospective review of 53 consecutive coronary artery bypass reoperations.
  • Exclusion of reoperations performed within 4 weeks of the prior surgery and complex procedures.
  • Comparison of reoperation data with 1775 primary CABG operations.

Main Results:

  • Postoperative mortality was 7.5% for reoperations versus 2.52% for primary CABG.
  • The average time between primary CABG and reoperation was approximately 90.7 months.
  • Graft patency rates were 34.6% for venous and 76.5% for arterial conduits during reoperation, with 54.7% receiving only venous grafts.

Conclusions:

  • While mortality in coronary reoperations is higher than in primary CABG, the difference is not statistically significant.
  • An increasing trend of elderly patients undergoing reoperative CABG was observed.
  • Progression of arterial atherosclerosis is a primary driver for reoperative CABG, with arterial conduits demonstrating long-term patency.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...